Mu-Hong Chen
Chief, Child and Adolescence Psychiatry Division, Taipei Veterans General Hospital; MD, PhD
Data updated
Research Footprint
Mu-Hong Chen appears in 5 tracked papers (2016–2023), most studied alongside Ketamine and Placebo, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Suicidality.
Most-cited paper: Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression (205 citations).
Frequent co-authors: Tung-Ping Su, Cheng-Ta Li and Wei-Chen Lin.
Background & Research
Mu-Hong Chen is a psychiatrist and MD/PhD clinician-researcher at Taipei Veterans General Hospital in Taipei, Taiwan. His work focuses on depression, anxiety, insomnia, and child/adolescent psychiatry, with a major research stream on ketamine treatment for treatment-resistant depression and suicidal ideation. He has been listed as Chief of the Child and Adolescence Psychiatry Division at Taipei Veterans General Hospital.
Key Impact
He is a prominent clinical psychiatrist and ketamine depression researcher whose studies helped characterize rapid antidepressant and antisuicidal effects of low-dose ketamine in treatment-resistant depression.
Collaboration Network
18 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Mu-Hong Chen is associated with.